Sign up
Pharma Capital

Callitas Health plans to launch CannaMint strips this summer

Callitas Health Inc (CSE:LILY, OTCQB:MPHMF) CEO James Thompson tells Proactive Investors the health and wellness company is planning on launching its patent-pending CannaMint strips in the next two months or so. The strips deliver THC orally.

Thompson says the company is currently producing samples and adding THC to the strips. He says the firm is planning to license the technology to manufacturers and distributors in North America.

Thompson adds the company has a new partner, to be announced, to help distribute its arousal gels.

 

View full LILY profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.